BBAGF
Healthcare BiotechnologyBB Biotech AG
$76.06
+0.00 +0.00% today
Price History
Not enough data
Key Stats
Market Cap
4.19B
Avg Volume
0
P/E (TTM)
7.61
EPS
$9.99
52W High
$76.06
52W Low
$33.65
Div. Yield
3.0%
Valuation
P/B Ratio
1.14
P/S Ratio
3.96
EV/Revenue
0.45
Margins
Gross Margin 100.0%
Operating Margin 97.7%
Net Margin 127.3%
EBITDA Margin 0.0%
Growth & Returns
Revenue Growth (YoY)
116257.7%
Return on Equity
54.8%
Return on Assets
25.9%
Liquidity & Leverage
Current Ratio
583.97
Quick Ratio
583.91
Total Cash
3.08B
Total Debt
0
About
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
www.bbbiotech.ch/en/bb-biotech/